2014 Opportunities in the Japanese Hematology and Flow Cytometry Markets
US$ 7,040.00
... suppliers and potential market entrants identify and evaluate business opportunities emerging in Japanese hematology and flow cytometry markets during the next ... years. The report explores business and technological trends in the Japanese hematology and flow cytometry markets; provides market share estimates ...
November 2013
250 pages
2014 Opportunities in the Spanish Hematology and Flow Cytometry Markets
US$ 4,960.00
... suppliers and potential market entrants identify and evaluate business opportunities emerging in Spanish hematology and flow cytometry markets during the next ... years. The report explores business and technological trends in the Spanish hematology and flow cytometry markets; provides market share estimates, ...
November 2013
255 pages
2014 Opportunities in the UK Hematology and Flow Cytometry Markets
US$ 4,960.00
... . Comprehensive lists of companies developingor marketing new technologies and products by test. Strategic Recommendations New product development opportunities with significant market appeal. Alternative market penetration strategies. Potential market entry barriers and risks. Contains 250 pages and ...
November 2013
250 pages
2014 Opportunities in the US Hematology and Flow Cytometry Markets
US$ 7,880.00
... . Comprehensive lists of companies developingor marketing new technologies and products by test. Strategic Recommendations New product development opportunities with significant market appeal. Alternative market penetration strategies. Potential market entry barriers and risks. Contains 275 pages and ...
November 2013
275 pages
2014 Opportunities in the European Microbiology Testing Market
US$ 15,760.00
Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. “2014 Analysis of the Microbiology Testing in Europe” is a new five-country strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report ...
November 2013
1600 pages
2014 Opportunities in the Global Cell Surface Testing Market
US$ 4,280.00
The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both ...
November 2013
120 pages
2014 Opportunities in the French Hemostasis Diagnostic Testing Market
US$ 4,880.00
... suppliers and potential market entrants identify and evaluate business opportunities emerging in the French coagulation testing market during the next five years. The report explores business and technological trends in the French coagulation testing market; provides estimates of the test volume, as well ...
November 2013
405 pages
2014 Opportunities in the German Hemostasis Diagnostic Testing Market
US$ 4,880.00
... suppliers and potential market entrants identify and evaluate business opportunities emerging in the German coagulation testing market during the next five years. The report explores business and technological trends in the German coagulation testing market; provides estimates of the test volume, as well ...
November 2013
406 pages
2014 Opportunities in the Italian Hemostasis Diagnostic Testing Market
US$ 4,880.00
... suppliers and potential market entrants identify and evaluate business opportunities emerging in the Italian coagulation testing market during the next five years. The report explores business and technological trends in the Italian coagulation testing market; provides estimates of the test volume, as well ...
November 2013
402 pages
2014 Opportunities in the Japanese Hemostasis Diagnostic Market
US$ 5,920.00
... and potential market entrants identify and evaluate business opportunities emerging in the Japanese coagulation testing market during the next five years. The report explores business and technological trends in the Japanese coagulation testing market; provides estimates of the test volume, as well as ...
November 2013
402 pages
2014 Opportunities in the Spanish Hemostasis Diagnostic Testing Market
US$ 4,880.00
... suppliers and potential market entrants identify and evaluate business opportunities emerging in the Spanish coagulation testing market during the next five years. The report explores business and technological trends in the Spanish coagulation testing market; provides estimates of the test volume, as well ...
November 2013
400 pages
2014 Opportunities in the UK Hemostasis Diagnostic Testing Market
US$ 4,880.00
... lists of companies developing or marketing new technologies and products by test. Strategic Recommendations Product development and business expansion opportunities with significant market appeal. “Ideal” product models with tentative prices and operating characteristics. Alternative market penetration ...
November 2013
409 pages
2014 Opportunities in the US Hemostasis Diagnostic Testing Market
US$ 7,680.00
... lists of companies developing or marketing new technologies and products by test. Strategic Recommendations Product development and business expansion opportunities with significant market appeal. “Ideal” product models with tentative prices and operating characteristics. Alternative market penetration ...
November 2013
424 pages
2014 Opportunities in the French Flow Cytometry Market
US$ 3,120.00
... leading reagent and instrument suppliers. Review of current and emerging diagnostic technologies, and their potential market applications. Product development opportunities for new instruments, consumables, and auxiliary products. Profiles of current and emerging suppliers, including their sales, product ...
November 2013
146 pages
2014 Opportunities in the German Flow Cytometry Market
US$ 3,120.00
... leading reagent and instrument suppliers. Review of current and emerging diagnostic technologies, and their potential market applications. Product development opportunities for new instruments, consumables, and auxiliary products. Profiles of current and emerging suppliers, including their sales, product ...
November 2013
147 pages
2014 Opportunities in the Italian Flow Cytometry Market
US$ 3,120.00
... leading reagent and instrument suppliers. Review of current and emerging diagnostic technologies, and their potential market applications. Product development opportunities for new instruments, consumables, and auxiliary products. Profiles of current and emerging suppliers, including their sales, product ...
November 2013
142 pages
2014 Opportunities in the Japanese Flow Cytometry Market
US$ 3,920.00
... leading reagent and instrument suppliers. Review of current and emerging diagnostic technologies, and their potential market applications. Product development opportunities for new instruments, consumables, and auxiliary products. Profiles of current and emerging suppliers, including their sales, product ...
November 2013
142 pages
2014 Opportunities in the Spanish Flow Cytometry Market
US$ 3,120.00
... leading reagent and instrument suppliers. Review of current and emerging diagnostic technologies, and their potential market applications. Product development opportunities for new instruments, consumables, and auxiliary products. Profiles of current and emerging suppliers, including their sales, product ...
November 2013
140 pages
2014 Opportunities in the UK Flow Cytometry Market
US$ 3,120.00
... leading reagent and instrument suppliers. Review of current and emerging diagnostic technologies, and their potential market applications. Product development opportunities for new instruments, consumables, and auxiliary products. Profiles of current and emerging suppliers, including their sales, product ...
November 2013
146 pages
2014 Opportunities in the US Flow Cytometry Market
US$ 5,360.00
... leading reagent and instrument suppliers. Review of current and emerging diagnostic technologies, and their potential market applications. Product development opportunities for new instruments, consumables, and auxiliary products. Profiles of current and emerging suppliers, including their sales, product ...
November 2013
174 pages
2014 Analysis of Enteric Diseases in France: Market Outlook and Emerging Opportunities
US$ 1,760.00
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the French Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...
November 2013
322 pages
2014 Analysis of Enteric Diseases in Germany: Market Outlook and Emerging Opportunities
US$ 1,760.00
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the German Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...
November 2013
322 pages
2014 Analysis of Enteric Diseases in Italy: Market Outlook and Emerging Opportunities
US$ 1,760.00
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the Italian Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...
November 2013
322 pages
2014 Analysis of Enteric Diseases in Japan: Market Outlook and Emerging Opportunities
US$ 2,080.00
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the Japanese Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia ...
November 2013
322 pages
2014 Analysis of Enteric Diseases in Spain: Market Outlook and Emerging Opportunities
US$ 1,760.00
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the Spanish Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...
November 2013
322 pages
2014 Analysis of Enteric Diseases in the UK: Market Outlook and Emerging Opportunities
US$ 1,760.00
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the UK Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...
November 2013
322 pages
2014 Analysis of Enteric Diseases in the US: Market Outlook and Emerging Opportunities
US$ 3,080.00
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the US Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...
November 2013
322 pages
2014 Analysis of the French Hospital Clinical Chemistry and Immunodiagnostics Market
US$ 3,080.00
This new report from Venture Planning Group contains 508 pages, 67 tables and presents a comprehensive analysis of the French hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the French clinical chemistry and immunodiagnostic hospital laboratory practice, as ...
November 2013
508 pages
2014 Analysis of the German Hospital Clinical Chemistry and Immunodiagnostics Market
US$ 3,080.00
This new report from Venture Planning Group contains 523 pages, 64 tables and presents a comprehensive analysis of the German hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the German clinical chemistry and immunodiagnostic hospital laboratory practice, as ...
November 2013
523 pages
2014 Analysis of the Italian Hospital Clinical Chemistry and Immunodiagnostics Market
US$ 3,080.00
This new report from Venture Planning Group contains 521 pages, 63 tables and presents a comprehensive analysis of the Italian hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the Italian clinical chemistry and immunodiagnostic hospital laboratory practice, as ...
November 2013
521 pages
2014 Analysis of the Japanese Hospital Clinical ChemistryAnd Immunodiagnostics Market
US$ 3,880.00
This new report from Venture Planning Group contains 520 pages, 64 tables and presents a comprehensive analysis of the Japanese hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the Japanese clinical chemistry and immunodiagnostic hospital laboratory practice, as ...
November 2013
520 pages
2014 Analysis of the Spanish Hospital Clinical Chemistry and Immunodiagnostics Market
US$ 3,080.00
This new report from Venture Planning Group contains 514 pages, 63 tables and presents a comprehensive analysis of the Spanish hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the Spanish clinical chemistry and immunodiagnostic hospital laboratory practice, as ...
November 2013
514 pages
2014 Analysis of the UK Hospital Clinical Chemistry and Immunodiagnostics Market
US$ 3,080.00
This new report from Venture Planning Group contains 523 pages, 64 tables and presents a comprehensive analysis of the UK hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the UK clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key ...
November 2013
523 pages
2014 Analysis of the US Hospital Clinical Chemistry and Immunodiagnostics Market
US$ 6,240.00
This new report from Venture Planning Group contains 543 pages, 63 tables and presents a comprehensive analysis of the US hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the US clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key ...
November 2013
543 pages
2014 Analysis of the US Hospital Infectious Disease Testing Market
US$ 5,440.00
This new report from Venture Planning Group contains 997 pages, 87 tables and presents a comprehensive analysis of the US hospital infectious disease testing market, including: Major issues pertaining to the US hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...
November 2013
997 pages
